Penwest Pharmaceuticals Patents – Insights & Stats (Updated 2024)

Penwest Pharmaceuticals has a total of 234 patents globally, out of which 105 have been granted. Of these 234 patents, more than 1% patents are active. Europe (EPO) is where Penwest Pharmaceuticals has filed the maximum number of patents, followed by Japan and India. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Penwest Pharmaceuticals.

Penwest Pharmaceuticals was founded in 1991. Penwest Pharmaceuticals develops healthcare products, specializing in drug delivery technologies for treating nervous system disorders.

Do read about some of the most popular patents of Penwest Pharmaceuticals which have been covered by us in this article and also you can find Penwest Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Penwest Pharmaceuticals patent portfolio.

How many patents does Penwest Pharmaceuticals have?

Penwest Pharmaceuticals has a total of 234 patents globally. These patents belong to 42 unique patent families. Out of 234 patents, 4 patents are active.

How Many Patents did Penwest Pharmaceuticals File Every Year?

Penwest Pharmaceuticals Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantPenwest Pharmaceuticals Applications FiledPenwest Pharmaceuticals Patents Granted
20141
201212
2011214
201027
2009155
2008117
2007315
20065018
2005415
20043811

How many Penwest Pharmaceuticals patents are Alive/Dead?

Worldwide Patents

Penwest Pharmaceuticals Patent Portfolio

How Many Patents did Penwest Pharmaceuticals File in Different Countries?

Penwest Pharmaceuticals Worldwide Patent Filing

Countries in which Penwest Pharmaceuticals Filed Patents

CountryPatent
Europe (EPO)25
Japan22
India21
United States of America18
Australia17
Hong Kong (S.A.R.)12
Mexico11
Germany11
Israel11
Austria9
Brazil8
Korea (South)7
Canada7
China5
Singapore5
Finland5
South Africa4
Indonesia3
Spain3
Denmark3
Philippines3
Norway2
Portugal2
Poland2
New Zealand2
Italy1
Taiwan1
Eurasian Patent Organization1
Hungary1

Where are Research Centers of Penwest Pharmaceuticals Patents Located?

R&D Centres of Penwest Pharmaceuticals

10 Best Penwest Pharmaceuticals Patents

US20070104778A1 is the most popular patent in the Penwest Pharmaceuticals portfolio. It has received 140 citations so far from companies like Supernus Pharmaceuticals, Oshadi Drug Administration, Biogen Idec Ma.

Below is the list of 10 most cited patents of Penwest Pharmaceuticals:

Publication NumberCitation Count
US20070104778A1140
WO2005027878A1111
US20050118267A173
WO2004012715A153
US20060193912A140
WO2006094083A132
US20040170684A130
JP2005537298A19
CN101578096A17
WO2008045060A115

What are Penwest Pharmaceuticals key innovation segments?

What Technologies are Covered by Penwest Pharmaceuticals?

The chart below distributes patents filed by Penwest Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Penwest Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has Penwest Pharmaceuticals search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Penwest Pharmaceuticals?

Related Articles

Xiamen Easo Patents – Insights & Stats (Updated 2024)

Xiamen Easo has a total of 681 patents globally, out of which 536 have been granted. Of these 681 patents, more than 59% patents are active. China is where Xiamen Easo has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, China seems

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.